Does brain aging raise Alzheimer’s risk more in women?

Yes, the link runs differently by sex. In a trial of adults with preclinical Alzheimer’s disease, a brain that scanned as older than its calendar age tracked with cognitive decline in a sex-dependent way. Same brain measurement, same scale, two different meanings depending on sex.

That finding comes from a new Nature Medicine study that built 38 separate biological aging clocks for women and men across 15 organ systems. Brain aging was only one piece of it, but it was the piece with the sharpest clinical edge.

What is a biological aging clock?

Your calendar age tells you how many birthdays you have had. It does not tell you how worn down any particular organ is. A biological aging clock tries to answer the second question. Researchers feed a computer model something measurable about your body, such as an MRI of your liver, the proteins floating in your blood, or your metabolites, and the model guesses how old you are. The gap between that guess and your real age is the score. The authors call it a biological age gap. A liver that scans like a 60-year-old’s in a 50-year-old body gives a gap of plus 10.

Almost all of these clocks so far were built by pooling women and men into one training set, which assumes without testing it that the aging process looks the same in both. This team tested that assumption by training the models separately. They built clocks from plasma proteins, from metabolites, and from MRI scans of individual organs, drawing on UK Biobank data along with the ADNI and A4 Alzheimer’s studies. On a held-out test set, the sex-split models predicted age about as well as the pooled versions, missing by roughly five years on average.

What the data show

The Alzheimer’s result is the one worth memorizing. In a clinical trial of people with preclinical Alzheimer’s disease, the brain aging clock tracked cognitive decline in a sex-dependent way, meaning the same amount of excess brain age did not carry the same weight in a woman as in a man.

The split showed up well outside the brain. The sex-specific clocks predicted whole-body systemic diseases and death from any cause, and which organ did the predicting depended on sex. In men the pattern was wider but flatter, with endocrine and immune aging clocks tracking high blood pressure, high cholesterol and several forms of diabetes, plus kidney disease, atrial fibrillation and knee osteoarthritis.

The underlying biology looked different too. The genetic analysis turned up parameters that differed between the sexes rather than one shared set, and the blood protein work mapped networks that resolved down to individual organs.

Dr. Kumar’s Take

The honest headline here is not “women age faster.” It is that a single number sold as your biological age may not mean the same thing in two different bodies. A brain age gap of plus five may not carry the same weight in a woman as the identical number does in a man. If the reference range used to generate that number came from a pooled male and female sample, part of what you are seeing is the model averaging away a real difference.

This matters commercially, not just academically. Biological age tests are being sold directly to consumers right now, and almost none of them publish sex-specific reference ranges.

The caution is that none of this was a treatment trial. These are prediction models built on observational data, so a fast clock flags risk, it does not prove that slowing the clock changes the outcome. And this was not a clean win for sex-split modeling across the board. The authors say directly that pooled and sex-interaction approaches stay useful, because much of human aging really is shared. They also caught one of their own models failing: the male eye clock hit a reasonable error rate while having essentially no correlation with real age, which is a good reminder that a single accuracy statistic can hide a broken model.

What happened in the prevention trial

The team also carried its brain aging clock into a clinical trial in preclinical Alzheimer’s disease, meaning adults who carry the biology of the disease but have no symptoms yet. There too the clock’s link to cognitive decline depended on sex, so a brain aging score at enrollment did not read the same way for women as for men in the same trial. That has obvious consequences for how future prevention trials get designed and read.

Important limitations

The genetic work was restricted to people of European ancestry, so none of the inherited patterns can be assumed to carry over to other populations. The researchers also had to pair their sex-split aging clocks with disease genetics that were still sex-pooled, because sex-stratified data for many conditions simply does not exist yet in the large genetic consortia. The UK Biobank imaging and blood data also have few repeat measurements, so this is largely a snapshot rather than a film of any one person aging.

Practical Takeaways

If you buy a consumer biological age test, ask whether the reference range it compares you against was built from a sex-matched healthy population, because a pooled range can shift your score in either direction.
Treat a high brain age score in the setting of existing memory complaints as a reason for a real neurologic workup, not as a standalone diagnosis, since the score predicted progression but says nothing about cause.
The metabolic aging signals in this study tracked with blood pressure, cholesterol and diabetes in both sexes, so the levers that matter are still the ordinary ones you can actually measure at a clinic visit.
Do not read a single organ’s score as a verdict on your whole body, because this study’s central point is that organs age on separate schedules within the same person.

FAQs

Should women get a brain age scan to check their Alzheimer’s risk?

Not on the strength of this study. The brain age measurement here was derived from research MRI scans processed through a trained model, not from a test you can order at an imaging center. Its link to cognitive decline also showed up inside an Alzheimer’s prevention trial, in people already enrolled in research and already getting a clinical workup.

Why would sleep show up in a study about aging clocks?

The researchers ran a genetic causal analysis linking disease risk to organ aging, and the signals for Alzheimer’s disease, sleep disturbance and psychiatric traits appeared in women and not in men. The sleep result was specific enough that they singled it out: genetic liability to sleep disorders was linked to the immune metabolic clock in women, and the same test in men, and in the pooled data, came back non-significant. The authors suggest sleep disruption may feed into immune and hormonal regulation differently in women. That is a hypothesis drawn from genetic data, not a demonstrated mechanism.

Does this mean aging research has been getting it wrong?

Not wrong, incomplete. The authors are careful on this point, and they argue against treating sex-split models as automatically better. Pooling men and women gives you a bigger sample, a more stable model, and a picture of the aging biology that both sexes truly share. What pooling costs you is the ability to tell shared aging from sex-specific aging, and to set a normal range that actually fits the person in front of you. Their recommendation is that all three approaches, sex-split, pooled and sex-interaction, get used depending on the question.

Bottom Line

Building aging clocks separately for women and men changed what those clocks predicted. The starkest example is Alzheimer’s disease, where the same amount of excess brain age tracked with cognitive decline differently in women and men. Beyond the brain, women’s metabolic aging signals tracked toward Alzheimer’s, sleep and psychiatric conditions, while men’s immune and endocrine signals tracked toward metabolic syndrome, diabetes and high blood pressure. A biological age number is only as good as the reference group behind it, and for now most of those reference groups are mixed.

Read the full study

Does brain aging raise Alzheimer's risk more in women?